Dalrada Accelerates Its National Healthcare Model With Acquisition of Watson Rx Solutions

Dalrada Corporation | June 09, 2022

Dalrada Accelerates

Dalrada Corporation announced that it had acquired the pharmacy, Watson Rx Solutions, Inc. The move highlights Dalrada’s aggressive growth plans within the healthcare sector and paves the way for a total end-to-end total healthcare solution.

Adding the 10-year-old pharmacy to Dalrada Health’s comprehensive model expands the subsidiary’s synergies with potential opportunities across its products and services portfolio and offers another solution to meet patient requirements.

Dalrada envisions a comprehensive healthcare solution for all Dalrada Health clients with unique offerings that will now include: a pharmacy to facilitate prescription processing, physicians and clinicians at treatment clinics, expanding into telemedicine, engagement of Dalrada-owned testing facilities and laboratories, and utilization of Company-specific technologies to facilitate immediate growth of the business.

Watson Rx has a long history of providing excellent pharmacy services. This acquisition allows Dalrada to expand its healthcare footprint and continue to build a total health management solution on an already successful turnkey operation. As a result, the Company will be able to successfully address the health needs of even more patients.”

CEO and Founder, Brian Bonar

Through comprehensive prescription management, education, nursing, and total health management, Watson Rx Solutions' leadership team holds more than six decades of combined experience in various complex pharmacy disease states and retail services, always putting patients first.

Dalrada plans on entering the pharmaceutical space with an accelerated strategic plan to leverage the Company’s existing capabilities. Research reveals that the U.S. online and mail-order sales of drugs, health, and beauty aids were valued at 75.5 billion USD in 2020. Additionally,

  • E-commerce pharmaceutical sales and beauty aids increased from 51.7 billion USD the year prior.
  • Online, E-commerce, and mail-order sales increased from around 31 to 38 percent during the same period.

Pharmacy and drug store sales reached 300 billion USD in 2020, with over-the-counter (OTC) medication accounting for over 36 billion USD in sales during the same year, the highest-selling year to date for the OTC segment. 

Dalrada and its subsidiaries provide value by making timely and impactful products and services available within health, technology, and clean energy markets. 

About Dalrada

Dalrada Corporation drives innovation that positively impacts people, businesses, and the planet. With subsidiaries that are firmly positioned in the world’s top three-growing industries of healthcare, clean energy, and technology, Dalrada creates solutions that are sustainable, affordable, and accessible.

The company works continually to produce disruptive products and services that accelerate positive change for current and future generations. Dalrada’s global solutions directly address climate change, post-pandemic gaps in the healthcare industry, and technology solutions for a new era of human behavior and interaction, ensuring a bright future for the world around us.



BMI Healthcare is the UK's largest private hospital group in the U.K, with 59 hospitals and clinics throughout the UK. What we do is in our name, it expresses its commitment to providing high quality healthcare, reiterating that there are two sides to healthcare; clinical expertise and caring support for the patient.


BMI Healthcare is the UK's largest private hospital group in the U.K, with 59 hospitals and clinics throughout the UK. What we do is in our name, it expresses its commitment to providing high quality healthcare, reiterating that there are two sides to healthcare; clinical expertise and caring support for the patient.

Related News


MedSec Sets Up a Healthcare Technology Cyber Risk Management Team

MedSec | July 04, 2022

In order to increase its biological and clinical knowledge, MedSec, a premier solutions provider of medical device security, announced it is forming a new Healthcare Technology Cyber Risk Management (HTCRM) team with a roster of seasoned professionals in the sector. The present Chief Product Officer of MedSec and HTCRM authority Phil Englert will take on the position of Advisor for the new team. "MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis." Justine Bone, CEO at MedSec "Biomedical and Clinical Engineering teams already have too many things on their plate – and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we're able to help our customers do things that they would otherwise not be capable of doing with their existing staff. Our clients love the combination of being able to 'speak tech' but also 'understand clinical' to help them further achieve their goals." Andrew Donarumo, Chief Technology Officer at MedSec Englert will continue to assist MedSec in creating security options for hospitals as an advisor. Englert brings to the position extensive understanding of clinical settings and medical technologies. His experience covers more than 30 years of technical and operational leadership in the healthcare and life sciences sector with an emphasis on creating strategic direction, enhancing operations, and undertaking business optimization and transformation efforts that are enabled by data and technology. In addition to governance and operations, vulnerability and patch management, incident response, medical device alerts, and SOC integration, Phil has led the development of medical device security programmes that have made it possible to prioritise strategic initiatives that will have an impact and carry out efficient maintenance and response tasks. In the past, he oversaw the development of strategy and tactics for a $250 million MedTech services business that supported over 130 Acute Care hospitals in 22 states.

Read More


ZetrOZ Systems Highlights the Rise in Health Insurance Denials, Provides Solution

ZetrOZ Systems | May 30, 2022

ZetrOZ Systems, leaders in wearable medical technology and makers of the sam® wearable ultrasound device that heals soft tissue, highlighted the rising health insurance claim denials. The organization is encouraging customers to inform themselves about their healthcare policies and challenge the first denial. Millions of people in the U.S. have experienced the devastating denial of their healthcare claims. According to Change Healthcare, 11% of 102 million medical claims at 1,500 hospitals are denied at first. The rate of denials has gone up by 20% since the year 2016. "Unfortunately, medical policies are driven by insurance company profits and fear of change. Thus, patients are often denied advanced new care when they need to access their healthcare benefits for soft tissue injuries." George K. Lewis, Ph.D. and CEO of ZetrOZ Systems "The first 'no' by an insurance policy can be turned into a 'yes' if you are informed and persistent," Lewis continued. "At ZetrOZ, we encourage patients and providers to not simply give up with the first denial of an insurance claim for therapies like Sustained Acoustic Medicine (sam®). Your insurance should always cover treatments that are proven to be both medically effective and cost-effective." If a denial letter is received, consumers can appeal against the decision. Possible issues include inaccurate paperwork, incorrect billing code, misplaced tax ID or wrongly coding the prescription or procedure. Inspite of sam®’s success, it is usually not covered by the first line of treatment. The reason is often an inadequate understanding of the costs and care by patients, insurers, and insurance providers.

Read More


NextGen Healthcare Expands Relationship with InstaMed to Simplify Payment Processing for Patients and Providers

NextGen Healthcare, Inc. | July 19, 2022

NextGen Healthcare, Inc, a leading provider of innovative, cloud-based healthcare technology solutions, announced that it has expanded its long-term relationship with InstaMed, a J.P. Morgan company, in a deal that modernizes payment processing through NextGen® Pay powered by InstaMed. This solution expands payment options and convenience for patients, who can pay online when visiting providers that utilize the NextGen® Practice Management solution. The platform also enables healthcare practices to automate collections and manage and view payments all in one system. The payment solution is not only convenient but secure, utilizing best-in-class data encryption protections. “With NextGen Pay powered by InstaMed, we’re taking the friction out of the patient-provider payment experience. Patients want a simple and streamlined process for paying their medical bills; providers want to focus on delivering the best care possible without being mired in collection inefficiencies. Our integrated solution delivers on both needs.” Srinivas (Sri) Velamoor, chief growth and strategy officer for NextGen Healthcare InstaMed is an industry leader in collecting healthcare payments throughout the patient journey. A recent trends report published by InstaMed highlights the importance of payment convenience to patients. According to the survey, 83% of patients want to continue using virtual and self-service options for care post-pandemic. Another 74% prefer online payment for medical bills. Additionally, 74% of millennials would switch providers for a better healthcare payment experience. “The expansion of our work with NextGen Healthcare is the evolution of our longstanding relationship rooted in delivering better healthcare payment experiences for both providers and patients,” said Jon Neal, head of business development at InstaMed and managing director at J.P.Morgan. “The demand and need for digital, automated and simple payment processes have never been higher. We are excited to see our solution drive real change for providers and patients.” Several NextGen Healthcare clients are already benefiting from NextGen Pay powered by InstaMed, which allows patients the convenience of saving credit card information within the online portal for quick payments on the go. With the expanded relationship, patients will also have the option to use Apple Pay® mobile payment solutions or Google Pay™ payment services at in-person care visits. “Now, our practice is a one-stop shop for patient collections,” said Matthew Pierre, chief executive officer of Loden Vision Centers, a NextGen Healthcare client based in Nashville. “The billing department can manage, view and collect payments all in one place. NextGen Pay powered by InstaMed improves the entire payment process, start to finish.” A webinar titled Trends in Healthcare Payments Annual Report: A Roadmap to the Future, set for July 21 at 2 p.m. EST, will delve into survey results and trends. Click here to register. About NextGen Healthcare, Inc. NextGen Healthcare, Inc. is a leading provider of innovative healthcare technology solutions. We are reimagining ambulatory healthcare with award-winning solutions that enable high-performing practices to create healthier communities. We partner with medical, behavioral and dental providers in their journey toward whole person health and value-based care. Our highly integrated, intelligent and interoperable solutions go beyond EHR and Practice Management to increase clinical quality and productivity, enrich the patient experience and drive superior financial performance. We are on a quest to achieve better healthcare outcomes for all. About InstaMed InstaMed, a J.P. Morgan company, is part of the firm’s Healthcare Payments business that supports clients across the Corporate and Investment Bank, Commercial Bank and Chase Business Bank. J.P. Morgan Healthcare Payments has integrated InstaMed’s solutions to deliver an end-to-end suite of payments, treasury, and banking solutions to healthcare organizations of all sizes. InstaMed powers a better healthcare payments experience and connects consumers, providers and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, processing payments and moving healthcare data seamlessly, and improving consumer satisfaction. Consumers, providers and payers benefit from InstaMed’s exclusive focus on healthcare, integration into any healthcare IT system, robust analytics and proven scale.

Read More